Cyfr21-1
WebSep 29, 2000 · CYFRA 21-1 measures soluble cytokeratin-19 fragments in serum and is a useful marker for lung carcinoma, especially squamous cell carcinoma (SCC). The … WebThis report focuses on the analytical performance of the high-sensitivity (hs)-CYFRA 21.1 assay in the context of quantifying the biomarker in two indeterminate pulmonary nodule (IPN) patient cohorts totaling 179 patients. Each of the ten assay calibrations consisted of 6 concentrations, each run as 7 replicates (e.g., 10 × 6 × 7 data points ...
Cyfr21-1
Did you know?
WebCYFRA 21-1 (Cytokeratin 19 Fragment) Interpret your laboratory results instantly with us. The CYFRA 21-1 is well known as tumor maker of lung cancer and is not influenced by … WebCYFRA 21-1 is a second-generation monoclonal immunoassay, detecting 21-1 fragments of cytokeratin 19. Function. The cytoskeleton is responsible for the physical three-dimensional architecture of the cell. During cell division, the cytoskeleton assumes a crucial, dynamic, and functional role. The precise function of individual cytokeratins is ...
WebSKU: 34082 Categories: Antibody Products, Cancer Research Antibodies, Products. Overview. Product Name Anti-CYFRA21-1 Antibody (34082) Description Anti-CYFRA21 … WebApr 22, 2015 · Meta-analysis of CYFRA 21-1 related to PFS was performed and pooled HR was 1.41 (95%CI = 1.19–1.69; P < 0.001). Our results indicate that high level of serum CYFRA 21-1 is a negative prognostic ...
WebNational Center for Biotechnology Information WebThe CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease …
WebAug 1, 1993 · Especially in squamous cell carcinomas of the lung, the true-positive test results were much higher for CYFRA 21-1 (60%) than for CEA (18%) or SCC (31%). In small cell lung carcinomas, NSE was ...
WebElevated Cyfra 21-1 levels might identify patients with high risk of failing treatment. Procedure for CYFRA 21 - Lung Cancer Marker Test. Few milliliters of blood would be obtained from you. The entire procedure will not take more than 15 minutes or so. A well-trained phlebotomist will assist you in the entire process. grampians aged care assessment serviceWebcyfRa 21-1 是细胞角蛋白ck19 的可溶性片段。细胞角蛋白是形成上皮细胞的结构蛋白之一———中间丝的亚单位,相对分子质量约 40 kd,是角蛋白家族中最小的成员。其广泛分 … china top chemical jiangsu co. ltdWebCYFRA-21 is a handy marker in the management of Non-Small Cell Carcinoma Lung (NSCCL). 85% of lung cancers are detected as NSCCL. The test has the tendency to show positivity in certain cases of Squamous cell carcinoma, large cell carcinoma and Adenocarcinoma. Preparation for CYFRA 21 - Lung Cancer Marker Test grampian saddlery workshopWebMar 21, 2024 · CEA + CYFRA 21-1 + CA-19-9 + CA-15-3 was the best tumor markers panel detecting 96% of cytologically negative malignant pleural effusions, with a negative predictive value of 98%. Conclusions. Although cytology is specific enough, it has less sensitivity in identifying malignant pleural fluids. As a result, the main gap is detecting … china top dishwasher detergentWebThe CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be china top computer glassesWebNov 1, 2024 · In 112 primary cancer patients, the diagnostic sensitivity of CYFRA 21-1 (33.9%) was superior to SCC-Ag (28.6%), CEA (12.5%), and CA19-9 (6.3%). Levels of CYFRA 21-1 were closely correlated with TNM stage and were below the cutoff value in all 21 patients with stage I disease. All 38 patients with a CYFRA 21-1 level over the cutoff … china top conyngham menuWebFSA-CIR is a rapid, mix-and-read, isothermal, label- and enzyme-free, matrix-insensitive, and target and probe-agnostic assay. Operating FSA-CIR at ∼40, 0.75 μL samples/day delivered a serum CYFRA 21-1 limit of quantification (LOQ) of 81 pg/mL with intra-assay and interassay CVs of 4.9% and 9.6% for four-day replicate determinations. grampians aboriginal country